AMZN
Amazon.com, Inc.
AMZN has the edge over CHDN overall, supported by stronger modeled upside and lower modeled downside.
CHDN
Churchill Downs Incorporated
CHDN offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
CHDN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Healthy | |
| Weak |
CHDN's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is weak.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over CHDN in the historical PE scenario, which offers more potential upside but is not a forecast.
CHDN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $99.62 | — |
| Current | 15x | $99.62 | — |
| Cheap | 17x | $107 | +7.6% |
| Fair | 22x | $143 | +44% |
| Expensive | 33x | $216 | +117% |
Historical ranges are pointers, not guarantees.
CHDN's PE is in its cheap range at 15x, but its recent earnings include one-off gains. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
CHDN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect CHDN's earnings to grow and its profitability to improve, with its revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over CHDN on earnings, with more consistent year-over-year improvement.
CHDN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.24 | +12% |
| Q3 2026 | $6.47 | +18% |
| Q2 2026 | $5.86 | +0.7% |
| Q1 2026 | $5.43 | -3.4% |
| Q4 2025 | $5.29 | -6.9% |
| Q3 2025 | $5.50 | -0.5% |
| Q2 2025 | $5.82 | +6.6% |
| Q1 2025 | $5.62 | +24% |
| Q4 2024 | $5.68 | +3.5% |
CHDN earned $6.47 per share over the past year, up 18% from the year before. Its recent earnings include one-off gains.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over CHDN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
CHDN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $696M | +1.9% |
| Q2 2026 | $980M | +4.9% |
| Q1 2026 | $663M | +3.2% |
| Q4 2025 | $665.9M | +6.7% |
| Q3 2025 | $683M | +8.7% |
| Q2 2025 | $934.4M | +4.9% |
| Q1 2025 | $642.6M | +8.7% |
| Q4 2024 | $624.2M | +11% |
CHDN's revenue has grown year over year for 16 quarters in a row: $696M last quarter, up 1.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | +6.2 points |
| Q2 2026 | 36% | +1.4 points |
| Q1 2026 | 22% | +0.6 points |
| Q4 2025 | 19% | -1.8 points |
| Q3 2025 | 14% | -5.7 points |
| Q2 2025 | 35% | -2 points |
| Q1 2025 | 21% | -0.4 points |
| Q4 2024 | 20% | +1.4 points |
CHDN has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
CHDN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $129M | -22% |
| Q2 2026 | $198M | -10% |
| Q1 2026 | $276M | +18% |
| Q4 2025 | $78.7M | -19% |
| Q3 2025 | $166.3M | +7.7% |
| Q2 2025 | $220.7M | +13% |
| Q1 2025 | $233.9M | -3.5% |
| Q4 2024 | $96.8M | +19% |
CHDN has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
CHDN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -1.4% | -1M shares |
| 3 years | -9.2% | -7.1M shares |
| 5 years | -11% | -8.4M shares |
| Available history | -14% | -11.2M shares |
CHDN has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $44M |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $32M |
| Q3 2025 | $54.9M |
| Q2 2025 | $254.5M |
| Q1 2025 | $86.4M |
| Q4 2024 | $27.3M |
CHDN spent $76M buying back its own shares over the past year, down 82% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over CHDN on leverage, with a lower net debt burden relative to earnings.
CHDN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.6x | High |
| Q2 2026 | 4.8x | High |
| Q1 2026 | 5.1x | High |
| Q4 2025 | 5.4x | High |
| Q3 2025 | 5.4x | High |
| Q2 2025 | 5.2x | High |
| Q1 2025 | 5.1x | High |
| Q4 2024 | 5.2x | High |
CHDN's net debt is about 4.5 years of its operating earnings (EBITDA), down from 5.4 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
CHDN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.8 | Neutral |
| Stochastic | 93.4 | Overbought |
CHDN's weekly RSI is 63 (neutral) and its Stochastic is 93 (overbought).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
CHDN PE vs Consumer Cyclical Sector
| Metric | CHDN | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 15% below |
| PE % | 5 | 47 | 42 pts below |
CHDN has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over CHDN on trend strength, trading above more of its moving averages.
CHDN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $86.7 | 15% above |
| 20 week MA | $87.0 | 15% above |
| 50 week MA | $92.0 | 8.3% above |
| 100 week MA | $99.2 | 0.5% above |
| 200 week MA | $114.2 | 13% below |
CHDN has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 13% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over CHDN on returns for 2026, with the stronger performance.
CHDN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $68.1 | $103.5 | +52% |
| 2021 | $103.5 | $118.2 | +14% |
| 2022 | $118.2 | $105.5 | -11% |
| 2023 | $105.5 | $134.9 | +28% |
| 2024 | $134.9 | $132.6 | -1.7% |
| 2025 | $132.6 | $114.5 | -14% |
| 2026 YTD | $114.5 | $99.6 | -13% |
CHDN has finished lower in three of the last six years. It's down 13% so far in 2026.